Idexx Laboratories Inc director Daniel M. Junius sells $844,889 of stock, cutting stake 34%
The sale reduces the insider's holding by 34%, the filing shows. Information only, not investment advice.
Daniel M. Junius sold about $840,000 of Idexx Laboratories Inc (IDXX) stock on Nov 4, according to an SEC filing. The director received an average of $704.07 for 1,200 shares.
The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. The insider still holds 2,361 shares after the sale, 34% fewer than before.
Four Idexx Laboratories Inc insiders sold on the open market within 14 days, a pattern known as a cluster sell. The trade was reported within two business days, as Section 16 requires.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | Idexx Laboratories Inc (IDXX) |
|---|---|
| Insider | Daniel M. Junius |
| Role | Director |
| Transaction | Open-market sale (code S) |
| Shares | 1,200 |
| Average price | $704.07 |
| Value | $844,889 |
| Trade date | Nov 4, 2026 |
| Filed with the SEC | Nov 5, 2026, 5:01 PM ET |
| Shares held after | 2,361 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See more details on this insider sale
See all insider activity at Idexx Laboratories Inc · See all the latest insider trades
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
Related Articles
- Insider Trading News
Idexx Laboratories Inc chair sells $17.7M in IDXX shares on the open market
- Insider Trading News
Cluster sell at Idexx Laboratories Inc: four insiders sell $27.4M of IDXX
- Insider Trading News
Idexx Laboratories Inc executive vice president Michael Lane sells $2.74M of IDXX shares
- Insider Trading News
Idexx Laboratories Inc officer Sharon E. Underberg sells $6.13M of IDXX shares
- Insider Trading News
Netflix Inc chief legal officer David A. Hyman sells $369,678 in stock